Skip to main content
View Cart

Journals in Oncology

  • Journal of Radiology Nursing

    • ISSN: 1546-0843
    Official journal of the Association for Radiologic & Imaging Nursing (ARIN)The Journal of Radiology Nursing promotes the highest quality patient care in the diagnostic and therapeutic imaging environments. The content is intended to show radiology nurses how to practice with compassion, competence, and commitment, not only to patients but also to the profession of nursing as a whole. The journal's goals mirror those of the Association for Radiologic & Imaging Nursing: to provide, promote, maintain, and continuously improve patient care through education, standards, professional growth, and collaboration with other health care providers.
    Subscriptions

  • Seminars in Oncology Nursing

    • ISSN: 0749-2081
    Seminars in Oncology Nursing (SON) is a unique, international peer-reviewed journal, published six times a year. It features special issues that offer a multi-faceted overview of a contemporary cancer topic, relevant to patient care, nursing education, management, and/or policy development. Each special issue is led by Guest Editors who solicit articles from invited expert authors. In addition to solicited articles, the Editor-in-Chief welcomes the submission of unsolicited original research and review articles. SON publishes on all aspects of cancer nursing, whether in the field of research, practice, or education.
    Subscriptions

  • Magnetic Resonance Imaging

    • ISSN: 0730-725X
    An International Journal of Basic Research and Clinical ApplicationsMagnetic Resonance Imaging (MRI) is the first international multidisciplinary journal encompassing physical, life, and clinical science investigations as they relate to the development and use of magnetic resonance imaging. MRI is dedicated to both basic research, technological innovation and applications, providing a single forum for communication among radiologists, physicists, chemists, biochemists, biologists, engineers, internists, pathologists, physiologists, computer scientists, and mathematicians.
    Subscriptions

  • International Journal of Radiation Oncology, Biology, Physics

    • ISSN: 0360-3016
    An official journal of the American Society for Radiation OncologyInternationa... Journal of Radiation Oncology - Biology - Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.The Red Journal's related publications are Practical Radiation Oncology and Advances in Radiation Oncology. Learn more about which types of papers these journals typically accept.Disclaimer No responsibility is assumed by the Publisher or the American Society for Radiation Oncology for any injury and/or damage to persons or property as a result of any actual or alleged libelous statements, infringement of intellectual property or privacy rights, products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.The views expressed in The Red Journal (the "Journal") are those of the individual authors and are not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The information contained in the Journal is not medical advice and is not intended to replace the judgment of a practitioner with respect to particular patients, procedures, or practice. No responsibility is assumed by the Publisher nor by the Society for any injury and/or damage to persons or property as a result of (i) any actual or alleged libelous statements or infringement of intellectual property or privacy rights, (ii) product liability or negligence; (iii) an author's statements or other materials; or (iv) the use or operation of any ideas, instructions, procedures, products, or methods contained in the Journal. Due to rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. In any jurisdiction that does not permit such a disclaimer of liability, the liability of ASTRO and the Publisher shall be limited to the greatest extent allowed by applicable law.Publication of an advertisement in the Journal does not constitute on the part of the Publisher or the Society a guarantee or endorsement of the quality or value of the advertised products or services described therein or of any of the representations or the claims made by the advertisers with respect to such products or services.
    Subscriptions

  • Gynecologic Oncology

    • ISSN: 0090-8258
    Gynecologic Oncology is the The Society of Gynecologic Oncology's (SGO) official peer-reviewed journal. It is dedicated to publishing high-quality science and educational content that addresses the full continuum of gynecologic cancer care.The Journal will publish innovative research that provides actionable insights related to prevention, detection, treatment and survivorship in gynecologic cancers. The focus of these publications will generally be clinically relevant and includes clinical trials, radiation and surgical innovation, health outcomes and diversity research, epidemiology, and patient-centered quality of life research. Translational research with promise to affect clinical treatment innovation will receive priority.With an international editorial board of experts and key opinion leaders, the Journal will support multiple stakeholders as they aim to solve complex gynecologic cancer problems. Providing essential reading for all stakeholders we will publish original research, invited reviews, editorials, perspectives, and correspondence. Importantly, as the official journal of the SGO, the Journal will publish communications from the SGO including abstracts, practice statements and guidelines.
    Subscriptions

  • Seminars in Oncology

    • ISSN: 0093-7754
    Seminars in Oncology brings you current, authoritative, and practical articles on advances in the etiology, diagnosis and management of cancer. The journal is dedicated to providing both the basic knowledge needed to better understand cancer-related subjects as well as evidence-based perspectives from leaders in the field. Seminars in Oncology also seeks to be a venue for sharing diverse viewpoints, including innovative and unconventional ideas that might be considered "outside the box". We encourage a healthy, constructive and respectful exchange of opinions and welcome your insights as well as suggestions for topics worthy of coverage. By deepening readers understand of the basic biology and therapy of cancer through expert insights, and by fostering an open exchange of ideas, Seminars in Oncology aims to advance the science and practice of cancer care.
    Subscriptions

  • Cellular Signalling

    • ISSN: 0898-6568
    Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo.Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.Cellular Signalling strives to offer a fair and fast peer-review process with a single round of revisions. Reviews are by invitation-only. Short Reports are not accepted.
    Subscriptions

  • Advances in Biological Regulation

    • ISSN: 2212-4926
    Advances in Biological Regulation (formerly Advances in Enzyme Regulation) reports cutting edge scientific progress on regulation at the molecular level, covering:The molecular biology of control of gene expression by hormones, drugs and growth factors in cancer cells and in clinical situations of metabolic diseases, inborn errors of metabolism and neoplasia.Stem cell biology and regenerative medicine issuesRegulatory networks, mainly in cellular signalling, differentiation, cell cycle & growth control, structure-function relationships, cell fate and lineage commitment or assembly mechanisms in cellsViruses, or supramolecular constructs, and signaling mechanisms mediating transcriptionGenomic... proteomic, bioinformatics and systems biology approaches to identify and characterize steps of biological control in cells.Complex cellular, pathogenic, clinical, or animal model systems studied by biochemical, molecular, genetic, epigenetic or quantitative ultrastructural approaches
    Subscriptions

  • Cancer Genetics

    • ISSN: 2210-7762
    The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.Cancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.
    Subscriptions

  • Cytokine & Growth Factor Reviews

    • ISSN: 1359-6101
    Cytokine & Growth Factor Reviews publishes focused research reviews (state-of-the-art reviews, correspondence, perspectives, meeting reviews) devoted to important advances in fields of cytokine and growth factor research. Major emphasis will be placed on reviews that detail molecular mechanistic analysis of diverse areas of biomedical research, including cytokine regulation of immune responses, innate immunity, viral pathogenesis, inflammatory disorders including neuroinflammation, growth regulation in cancer, cytokines in the tumor microenvironment and cytokine-guided immunotherapeutic strategies. Priority will be given to those reviews with a focused expert perspective, provided by scientific leaders in their respective areas of research. Broad literature reviews with an overview perspective rather than a research focus should consider other Elsevier venues.
    Subscriptions